The serum samples of 100 HIV positive patients on medication (protease inhibitors) 
Introduction
Blood sugar is the amount of glucose in the blood. Glucose, transported via the bloodstream, is the primary source of energy for the body's cells. Blood sugar concentration, or glucose level, is tightly regulated in the human body. Normally, the blood glucose level is maintained between about 4 and 6 mmol/L. Normal blood glucose level (homoeostasis) is about 90mg/100ml or 5mM. The total measurement of glucose in the circulating blood is therefore about 3.3 to 7g (assuming an ordinary adult blood volume of 5 liters) [1] . Glucose levels rise after meals and are usually lowest in the morning, before the first meal of the day. Failure to maintain blood glucose in the normal range leads to conditions of persistently high (hyperglycemia) or low (hypoglycemia) blood sugar. Only glucose levels are regulated via insulin and glucagon [ 1] Two types of HIV exist: HIV-1 and HIV-2. HIV-1 is more virulent, is more easily transmitted and is the cause of the vast majority of HIV infections globally [2] . The pandemic strain of HIV-1 is closely related to a virus found in the chimpanzees of the subspecies Pan troglodytes troglodytes, which lives in the forests of the Central African nations of Cameroon, Equatorial Guinea, Gabon, Republic of Congo (or Congo-Brazzaville), and Central African Republic. HIV-2 is less transmittable and is largely confined to West Africa, along with its closest relative, a virus of the sooty mangabey (Cercocebus atys atys), an Old World monkey inhabiting southern Senegal, Guinea-Bissau, Guinea, Sierra Leone, Liberia, and western Ivory Coast [2] [3] . Most HIV patients have been found to develop a diabetic condition primarily out of the medications prescribed in the treatment of the HIV complication. Since this onset of abnormal blood glucose is considered Type II diabetes, the patient can usually manage the irregularity with diet and exercise, occasionally requiring the use of insulin injections [1] . The economic costs of diabetes globally was estimated in 2013 at $548 billion [16] and in the United States in 2012 $245 billion [4] .
Protease inhibitors (PIs) are a class of medications used to treat or prevent infection by viruses, including and Hepatitis C. PIs prevent viral replication by inhibiting the activity of HIV-1 protease, an enzyme used by the viruses to cleave nascent proteins for final assembly of new virons figure 1. Protease inhibitors have been developed or are presently undergoing testing for treating various virus; HIV/AIDS: antiretroviral protease inhibitors (saquinavir, ritonavir, indinavir, nelfinavir etc.) [5] . All protease inhibitors work in the same manner. They block the activity of the protease enzyme within human cells or new virus particles. This enzyme is what allows a virus to undergo final maturation figure4 for producing new viruses that can go out and infect other cells. When the PIs bind to the enzyme, the new viruses still leave the cell, but they are unable to infect other cells [6] .. HIV is a virus that goes through many steps during it's' life cycle figure 2. Once HIV infects a human cell, the virus uses proteins and chemicals inside that cell to make more copies of it. Protease figure1 is a chemical, known as an enzyme that HIV needs in order to make new viruses [6] .
If untreated, eventually most HIV-infected individual develop AIDS (Acquired Immunodeficiency Syndrome) and die; however, about one in ten remains healthy for many years with no noticeable symptoms . [7] . Treatment with anti-retroviral, where available, increases the life expectancy of people infected with HIV. Protease inhibitors (PIs) block the protease enzyme. When protease is blocked, HIV makes copies of itself that can't infect new cells [8] . Studies have shown that protease inhibitors can reduce the amount of virus in the blood and increase CD4 cell counts. In some cases these drugs have improved CD4 cell counts, even when they were very low or zero [9] [10].
Justificati0n
Most HIV patients commonly experience greater degrees of blood glucose fluctuations and are at a greater risk for the secondary complications associated with abnormal blood glucose, including infection due to the medications and the therapies used to treat them, but little or no information are available in this part of the country on these complications.
Aims And Objectives

1.
To estimate the level of serum glucose in HIV patients on medication (Protease Inhibitor) 2.To estimate the level of serum glucose in HIV patients without medication (Protease Inhibitor). 3. To compare the levels of glucose in patients on medication with patients not on medication.
II.
Material And Method
Sample Collection
A total of 200 samples were collected from Faith Alive Foundation, Jos Plateau State. The samples were collected from both sexes within age 20-60 out of this number, 100 was collected from HIV patient on medication (Protease Inhibitors) and 100 from HIV patient not on medications. 2ml of venous blood was collected by venipuncture after sterilizing the Cubital Fossa with methylated spirit and avoiding venous stasis. Each sample was transferred into an appropriately labeled clean dry sample bottles. This was allowed to stand for 30minutes for it to clot and retract. It was then centrifuge at 3000 revolution per minute (rpm) for 5minutes. The serum was estimated immediately and the absorbance reading was taken at 500nm.
Inclusion criteria
HIV patients only HIV patients on protease inhibitor only HIV patients who has not developed AIDS HIV patients on protease inhibitor from two weeks and above. HIV patients with CD4+ count of two hundred and fifty and above
Exclusion criteria
Non HIV positive patients HIV patients on drugs other than protease inhibitor HIV patients who has developed AIDS HIV patients less than two weeks on protease inhibitor HIV patients with CD4+ count of less than two hundred and fifty 2.2 Method:Estimation Of Serum Glucose Using Dialab Liquid Reagent.
Procedure
1000µl of the reagent was pipetted into dried cleaned test tubes labeled Sample, Blank and Standard each. 100µl of the sample and standard was added to the reagents and distilled water was used for the blank to make up the volume. It was mixed and incubated for 10minutes at 37°C and absorbance reading was taken at 500nm.
Calculation:
Glucose concentration = Abs. of Test × Conc. of Std. Abs. of Std. The mean difference is signi ficant at the .05 l ev el . *.
III. Result
IV. Discussion
The result obtained from the work done shows that the glucose level of the HIV patients that are positive and on medication was higher than those not on medication. The average glucose level of the male test and control were 4.97 and 4.94 respectively and the female test and control were 5.43 and 4.84 respectively. The glucose level in test male and female were therefore higher than control. This is in agreement with the study carried out by [11] [16] which states that there was relatively rapid development of insulin resistance after the initiation of protease inhibitor therapy and when evaluated, fasting insulin and glucose levels as well as insulin resistance increased significantly. Also in another work done by [17] [18] . firstgeneration protease inhibitors, including the drug ritonavir, block GLUT4, a protein that transports glucose from the blood into the cells where it is needed. This raises blood sugar levels -a hallmark of diabetes.
In table 1, it was observed that comparison of mean serum glucose between the male and female test against male and female controls was not significant. This may probably be due to the fact that the side effect of the drug on the patients have not begun to show and genetic factors have also been implicated in the way an individual responds to side effect of any drug visa vis: absorption, distribution and elimination of the drug [19] . This was also observed in table 2 in which comparison based on age group was seen to be generally not significant p>0.05. But comparison within the age group of the tests showed that age group 41-50 with mean (5.647) was higher than the other age group and significant p<0.05.
There was a significant difference between pair wise comparison as well as post hoc tests of female test and female control while male test and male control had no such significant difference p>0.05 tables 3, 4, and 5 which may be due to the fact that men demonstrated an increased rate of insulin clearance and increased peripheral tissue sensitivity to insulin when compared to non HIV-infected controls [20] In addition diabetes mellitus is associated with such long-term complications as retinopathy figure 3, nephropathy, and neuropathy. It currently accounts for more cases of loss of vision, renal failure, and amputation figure 4 than any other disease [21] . However, even more importantly, persons with diabetes mellitus have two to five times the risk of cardiovascular disease than persons without the disease and the majority of patients with diabetes mellitus die of cardiovascular disease. Furthermore the Food and Drug Administration warned doctors to closely monitor patients on protease inhibitors because of reports of hyperglycemia and diabetes mellitus associated with protease inhibitors. After this warning, physicians continued to report cases of hyperglycemia and diabetes mellitus in association with protease inhibitors. Two retrospective studies suggested that the incidence of newonset diabetes mellitus after initiation of protease inhibitor therapy is between 6% and 7% [ 13] [22] found that HIV-infected persons taking the protease inhibitor indinavir for only a few weeks developed fasting hyperglycemia and decreased insulin sensitivity, typical predictors of future diabetes mellitus [23] 
V. Conclusion
From the results obtained, the glucose level of the HIV patients on medication (protease inhibitor) was higher than of the HIV patients not on medication and this could result to metabolic disorders such as diabetes mellitus, ketoacidosis, atherosclerosis and other preventable diseases.
VI. Recommendation
We therefore recommend that glucose levels of HIV patients on protease inhibitors should be closely monitored.
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Image of fundus showing scatter laser surgery for diabetic retinopathy
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Foot ulcers are a common complication of diabetes and can lead to amputation. This ulcer is further complicated by both wet and dry gangrene.
